Article
Patient-reported endometriosis symptom change during GLP-1 receptor agonist use, and its relationship to weight loss: an international cross-sectional survey (GLEAM)
2026-07-14
Abstract excerpt
<title>Abstract</title> <p>Background. Patient communities report endometriosis and adenomyosis symptom change during glucagon-like peptide-1 receptor agonist (GLP-1 RA) use, including among people who lost little or no weight. A prior international survey documented this improvement signal but did not test whether improvement is independent of weight loss. Because weight loss alone can reduce pelvic and systemic...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 530bde99-50b1-5252-a584-4b2ed128bd56
- DOI
- 10.21203/rs.3.rs-10323555/v1
